Both individuals with MEN1 pathogenic variants were diagnosed with MEN 1-related features, one with primary hyperparathyroidism and a leiomyoma and the second with primary hyperparathyroidism, a leiomyoma, and a pituitary adenoma. This evidence concerns the gene MEN1 and leiomyoma.